No Data
No Data
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Caribou Biosciences Analyst Ratings
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Cuts Target Price to $6
Express News | Caribou Biosciences Inc : Citigroup Cuts Target Price to $6 From $30
Caribou Biosciences Reports Q3 2024 Financial Results
Caribou Biosciences to Participate in Upcoming Investor Conferences
No Data